
DARPA at NDFS 2025
February 3, 2025/by Ayal Ronen
NSCEB at the NDFS 2025
February 3, 2025/by Ayal Ronen
Navigating Transition Periods in Government: A Closer Look at the NIH Pause
January 26, 2025/by Ayal Ronen
Formation Venture Engineering – FreeMind Elite
January 6, 2025/by Ayal Ronen
New England Hemolytics – FreeMind Elite
January 6, 2025/by Ayal Ronen
BioVie – FreeMind Elite
January 6, 2025/by Ayal Ronen
Nemysis – FreeMind Elite
January 6, 2025/by Ayal Ronen
4J Therapeutics – FreeMind Elite
January 6, 2025/by Ayal Ronen
NIH Funding during the first Trump Administration; Driving Growth in Non-Basic Research and Supporting the Life Sciences Industry
December 18, 2024/by Ayal Ronen
4J Therapeutics Secures Major BARDA Contract
November 6, 2024/by Ayal Ronen
Grant Tips & Tricks: Straight from the FreeMind Group Experts
October 10, 2024/by Ayal Ronen
LSX Nordic Congress, October 8-9, 2024, Copenhagen, Denmark
September 29, 2024/by Ayal RonenSearch
Recent Posts
SBIR Is Back — Here’s What Changed and What You Need to Do NowJune 16, 2026 - 8:03 am
BIO-Europe, November 9-11, 2026, Cologne, GermanyJune 14, 2026 - 7:16 am
SBIR/STTR Program Updates: What Life Science Companies Need to Know in 2026June 2, 2026 - 12:03 pm
RESI San Diego, June 22, 2026 in San DiegoMay 26, 2026 - 9:29 am
CDMRP Funding Opportunities 2026: What Life Science Companies Should Apply ForMay 7, 2026 - 9:35 am
